Indeterminate Cell Histiocytosis Treated Successfully with 2-Chlorodeoxyadenosine

Cutis

Volumn 59, Issue 1, 1997, Pages 27-31

  Daoud, Mazen S ^a,c   Dahl, Patrick R ^a   Dicken, Charles H ^a   Phyliky, Robert L ^b  

^a MAYO CLINIC ROCHESTER   (United States)

^b Division of Hematology   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE;

ADULT; ARTICLE; CASE REPORT; DISEASE CLASSIFICATION; ERYTHEMA; HISTIOCYTE; HISTIOCYTOSIS; HUMAN; MALE; PAPULAR SKIN DISEASE;

CLADRIBINE; HISTIOCYTOSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED;

EID: 0031012566     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Nestle FO, Nickoloff BJ: Role of dendritic cells in benign and malignant lymphocytic infiltrates of the skin. Dermatol Clin 12: 271-821, 1994.
2. Pimpinelli N, Santucci M, Romagnoli P, et al: Dendritic cells in T- and B-cell proliferation in the skin. Dermatol Clin 12: 255-270, 1994.
3. Wood GS, Hu CH, Beckstead JH, et al: The indeterminate cell proliferative disorders; report of a case manifesting as an unusual cutaneous histiocytosis. J Dermatol Surg 11: 1111-1119, 1985.
4. Levisohn D, Seidel D, Phelps A, et al: Solitary congenital indeterminate cell histiocytoma. Arch Dermatol 129: 81-85, 1993.
5. Hui PK, Feller AC, Kaiserling E, et al: Skin tumor of T accessory cells (interdigitating reticulum cells) with high content of T lymphocytes. Am J Dermatopathol 9: 129-137, 1987.
6. Kolde G, Brocker EB: Multiple skin tumors of indeterminate cells in an adult. J Am Acad Dermatol 15: 591-597, 1986.
7. Berti E, Gianotti R, Alessi E: Unusual cutaneous histiocytosis expressing an indeterminate immunophenotype between Langerhans' cells and dermal macrophages. Arch Dermatol 124: 1250-1253, 1988.
8. Saijo S, Hara M, Kuramoto Y, et al: Generalized eruptive histiocytoma: a report of a variant case showing the presence of dermal indeterminate cells. J Cutan Pathol 18: 134-136, 1991.
9. Winkelman RK, Hu CH, Kossard S: Response of nodular non-x histiocytosis to vinblastine. Arch Dermatol 118: 913-917, 1982.
10. Saven A, Foon KA, Piro LD: 2-Chlorodeoxyadenosine-induced complete remission in Langerhans-cell histiocytosis. Ann Intern Med 121: 430-432, 1994.
11. Narvaez D, Kanitakis J, Claudy A: Dendritic cells of human dermis. Eur J Dermatol 5: 69-76, 1995.
12. Bartosik J: The non-keratinocytes in normal epidermis. Eur J Dermatol 1: 131, 1991.
13. Breathnach AS: Variation in ultrastructural appearance of Langerhans cells of normal human epidermis. Br J Dermatol 97(Suppl 15): 14, 1977.
14. Murphy GF, Ban AK, Harris TJ, et al: In situ identification of T6-positive cells in normal human dermis by immunoelectron microscopy. Br J Dermatol 108: 423-431, 1983.
15. Rowden G, Phillips TM, Lewis MG: Ia antigens on indeterminate cells of the epidermis: immunoelectron microscopic studies of surface antigens. Br J Dermatol 100: 531-542, 1979.
16. Bani D, Pimpinelli N, Moretti S, et al: Langerhans cells and mycosis fungoides - a critical overview of their pathogenic role in the disease. Clin Exp Dermatol 15: 7-12, 1990.
17. Rowden G, Lewis MG: Langerhans cells: involvement in the pathogenesis of mycosis fungoides. Br J Dermatol 95: 665-672, 1976.
18. Guchelaar HJ, Richel DJ, Schaafsma MR: Clinical and toxological aspects of the antineoplastic drug cladribine: a review. Ann Hematol 69: 223-230, 1994.
19. Santana VM, Mirro J Jr, Kearns C, et al: 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia. J Clin Oncol 10: 364-370, 1992.
20. Saven A, Carrera CJ, Carson DA, et al: 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma. Blood 80: 587-592, 1992.
21. Kay AC, Saven A, Carrera CJ, et al: 2-Chlorodeoxyadenosine treatment of low grade lymphomas. J Clin Oncol 10: 371-377, 1992.
22. Estey EH, Kurzrock R, Kantarjian HM, et al: Treatment of hairy cell leukemia with 2-Chlorodeoxyadenosine (2-CdA). Blood 79: 882-887, 1992.
23. Hickish T, Serafinowski P, Cunningham D, et al: 2-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies. Br J Cancer 67: 139-143, 1993.
24. Niesvizky R, Siegel DS, Michaeli J: 2-Chlorodeoxyadenosine for multiple myeloma [letter]. Blood 81: 868-869, 1992.